Alan Messenger, Sales Director at Optimal Industrial Automation, and Manuel Kuhs, Business Development Manager for Europe at Optimal Industrial Technologies, look at the importance of PAT software for Pharma 4.0-oriented data management.
MGC Pharmaceuticals' Malta facility has received formal EU-Good Manufacturing Practice (GMP) certification, enabling the production of high-quality plant-inspired medicines such as CannEpil and CimetrA. The large-scale facility can produce over 20
Q&A with Kimberly Remillard, RAC, senior regulatory affairs manager at Thermo Fisher Scientific, examines how leveraging the power of Pharma 4.0 can ensure data integrity within biopharma.
2023 will bring new regulatory changes linked to process digitalisation and automation, REPHINE’s Dr. Eduard Cayón discusses the implications for quality control and how pharma companies can stay ahead of the curve.
Kay Scheffler, product manager - applied microscopy at Leica Microsystems, explains how microscopy is key in identifying particle contamination and ensuring quality control in the pharma industry.
Rebekah Jordan spoke with Katrin Pauls (Lonza), Mark Hilhorst (Jekson Vision), and Christoph Jansen (Mettler Toledo), to discuss the factors and challenges involved in the pharma industry's move towards sustainable, future-proofed QC lab testing.
Jason Boyd, senior director, Vault LIMS, Veeva Systems, gives three ways in which digital strategies can modernise quality control by creating a holistic view of workflow and quality data in biopharma lab operations.
Kerstin Pohl, sr. global manager, Gene Therapies, at SCIEX, and Thomas Kofoed, co-founder of Alphalyse, discussed the harmful effects of HCPs and strategies to mitigate them.
Phil Nethercote, independent pharmaceutical industry consultant and Stephanie Harden, global pharmaceutical marketing manager, Waters, discuss the types of error mitigation tools that ensure the quality of data and products among pharma companies.
Allen Burgenson, associate director, Global Subject Matter (SME) Testing, Lonza, discusses the a more sustainable route to future-proof testing and quality control in pharma.
